To control for their ability to target TRF2-overexpressing cancers, we analyzed the potential anti-tumorigenic effects of AR and AD on both standard BJ-HELTRas cells and TRF2-overexpressing BJ-HELTRas cells. This evidence concerns the gene TERF2 and cancer.